Pitcairn CO Laboratory Corp Of America Holdings Transaction History

Pitcairn CO

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$204.81 - $262.19 $213,616 - $273,464	-1,043 Reduced 34.76%	1,958 $401,000
Q2 2022 Aug 12, 2022	SELL	$213.86 - $277.87 $54,748 - $71,134	-256 Reduced 7.86%	3,001 $703,000
Q1 2022 May 12, 2022	SELL	$259.82 - $298.18 $12,991 - $14,909	-50 Reduced 1.51%	3,257 $859,000
Q4 2021 Feb 14, 2022	BUY	$271.6 - $314.21 $661,346 - $765,101	2,435 Added 279.24%	3,307 $1.04 Million
Q3 2021 Nov 10, 2021	BUY	$274.82 - $308.34 $239,643 - $268,872	872 New	872 $245,000
Q4 2019 Feb 12, 2020	SELL	$163.48 - $173.61 $599,644 - $636,801	-3,668 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$159.77 - $178.1 $14,698 - $16,385	-92 Reduced 2.45%	3,668 $616,000
Q2 2019 Aug 12, 2019	SELL	$144.16 - $172.9 $36,616 - $43,916	-254 Reduced 6.33%	3,760 $650,000
Q1 2019 May 07, 2019	BUY	$123.7 - $156.3 $496,531 - $627,388	4,014 New	4,014 $614,000

113

2.32M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.4B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Pitcairn CO, based on Form 13F filings with the SEC.

Stay updated on Pitcairn CO with notifications on news.